Matrix Metalloproteinase Inhibition After Myocardial Infarction: A New Approach to Prevent Heart Failure?
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Increased activity of matrix metalloproteinases (MMPs) has been implicated in numerous disease processes, including tumor growth and metastasis, arthritis, and periodontal disease. It is now becoming increasingly clear that extracellular matrix degradation by MMPs is also involved in the pathogenesis of cardiovascular disease, including atherosclerosis, restenosis, dilated cardiomyopathy, and myocardial infarction. Administration of synthetic MMP inhibitors in experimental animal models of these cardiovascular diseases significantly inhibits the progression of, respectively, atherosclerotic lesion formation, neointima formation, left ventricular remodeling, pump dysfunction, and infarct healing. This review focuses on the role of MMPs in cardiovascular disease, in particular myocardial infarction and the subsequent progression to heart failure. MMPs, which are present in the myocardium and capable of degrading all the matrix components of the heart, are the driving force behind myocardial matrix remodeling. The recent finding that acute pharmacological inhibition of MMPs or deficiency in MMP-9 attenuates left ventricular dilatation in the infarcted mouse heart led to the proposal that MMP inhibitors could be used as a potential therapy for patients at risk for the development of heart failure after myocardial infarction. Although these promising results encourage the design of clinical trials with MMP inhibitors, there are still several unresolved issues. This review describes the biology of MMPs and discusses new insights into the role of MMPs in several cardiovascular diseases. Attention will be paid to the central role of the plasminogen system as an important activator of MMPs in the remodeling process after myocardial infarction. Finally, we speculate on the use of MMP inhibitors as potential therapy for heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, M. A., & Braunwald, E. (1990) · Circulation · doi:10.1161/01.cir.81.4.1161 · Cited by 2,877
A matrix metalloproteinase expressed on the surface of invasive tumour cells
Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., & Seiki, M. (1994) · Nature · doi:10.1038/370061a0 · Cited by 2,551
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
Gomez, D. E., Alonso, D. F., Yoshiji, H., & Thorgeirsson, U. P. (1997) · PubMed · Cited by 1,508
Processing of tumour necrosis factor-α precursor by metalloproteinases
Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., et al. (1994) · Nature · doi:10.1038/370555a0 · Cited by 1,194
Activation mechanisms of matrix metalloproteinases.
Nagase, H. (1997) · PubMed · Cited by 1,119
Matrix Metalloproteinase-2 Is an Interstitial Collagenase
Aimes, R. T., & Quigley, J. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.5872 · Cited by 944
Ducharme, A., Frantz, S., Aikawa, M., Rabkin, E., Lindsey, M., Rohde, L. E., Schoen, F. J., Kelly, R. A., Werb, Z., Libby, P., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8768 · Cited by 808
Heymans, S., Luttun, A., Nuyens, D., Theilmeier, G., Creemers, E., Moons, L., Dyspersin, G. D., Cleutjens, J. P. M., Shipley, M., Angellilo, A., et al. (1999) · Nature Medicine · doi:10.1038/13459 · Cited by 794
Self-citationMechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin.
Lyons, R. M., Gentry, L. E., Purchio, A. F., & Moses, H. L. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.4.1361 · Cited by 737
Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E., & Iwata, K. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80015-9 · Cited by 695
Schönbeck, U., Mach, F., & Libby, P. (1998) · PubMed · Cited by 681
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
Carmeliet, P., Moons, L., Lijnen, R., Baes, M., Lemaître, V., Tipping, P., Drew, A., Eeckhout, Y., Shapiro, S., Lupu, F., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-439 · Cited by 661
Furin-dependent intracellular activation of the human stromelysin-3 zymogen
Pei, D., & Weiss, S. J. (1995) · Nature · doi:10.1038/375244a0 · Cited by 629
Zhang, B., Ye, S., Herrmann, S.-M., Eriksson, P., de Maat, M., Evans, A., Arveiler, D., Luc, G., Cambien, F., Hamsten, A., et al. (1999) · Circulation · doi:10.1161/01.cir.99.14.1788 · Cited by 611
Matrix metalloproteinases in skin
Kähäri, V., & Saarialho‐Kere, U. (1997) · Experimental Dermatology · doi:10.1111/j.1600-0625.1997.tb00164.x · Cited by 607
Schönbeck, U., Mach, F., & Libby, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3340 · Cited by 595
Kai, H., Ikeda, H., Yasukawa, H., Kai, M., Seki, Y., Kuwahara, F., Ueno, T., Sugi, K., & Imaizumi, T. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00250-2 · Cited by 590
Tumor targeting with a selective gelatinase inhibitor
Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O. P., Heikkilä, P., Kantor, C., Gahmberg, C. G., Salo, T., Konttinen, Y. T., et al. (1999) · Nature Biotechnology · doi:10.1038/11703 · Cited by 567
Molecular Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinase 4
Greene, J., Wang, M., Liu, Y. E., Raymond, L. A., Rosen, C., & Shi, Y. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30375 · Cited by 555
Regulation of collagen degradation in the rat myocardium after infarction
CLEUTJENS, J., KANDALA, J., GUARDA, E., GUNTAKA, R., & WEBER, K. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(05)82390-9 · Cited by 479
Self-citationSpinale, F. G., Coker, M. L., Heung, L. J., Bond, B. R., Gunasinghe, H. R., Etoh, T., Goldberg, A. T., Zellner, J. L., & Crumbley, A. J. (2000) · Circulation · doi:10.1161/01.cir.102.16.1944 · Cited by 476
Baker, A. H., Zaltsman, A. B., George, S. J., & Newby, A. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1584 · Cited by 464
Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2)
Hayakawa, T., Yamashita, K., Ohuchi, E., & Shinagawa, A. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.9.2373 · Cited by 451
Thomas, C. V., Coker, M. L., Zellner, J. L., Handy, J. R., Crumbley, A. J., & Spinale, F. G. (1998) · Circulation · doi:10.1161/01.cir.97.17.1708 · Cited by 443
Rohde, L. E., Ducharme, A., Arroyo, L. H., Aikawa, M., Sukhova, G. H., Lopez-Anaya, A., McClure, K. F., Mitchell, P. G., Libby, P., & Lee, R. T. (1999) · Circulation · doi:10.1161/01.cir.99.23.3063 · Cited by 437
Cytokine regulation of metalloproteinase gene expression
Mauviel, A. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240530404 · Cited by 432
Wang, H., & Keiser, J. A. (1998) · Circulation Research · doi:10.1161/01.res.83.8.832 · Cited by 427
Ye, S. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00102-5 · Cited by 380
Differential Expression of Tissue Inhibitors of Metalloproteinases in the Failing Human Heart
Li, Y. Y., Feldman, A. M., Sun, Y., & McTiernan, C. F. (1998) · Circulation · doi:10.1161/01.cir.98.17.1728 · Cited by 372
Spinale, F. G., Coker, M. L., Thomas, C. V., Walker, J. D., Mukherjee, R., & Hebbar, L. (1998) · Circulation Research · doi:10.1161/01.res.82.4.482 · Cited by 372
Sato, H., Kinoshita, T., Takino, T., Nakayama, K., & Seiki, M. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00861-7 · Cited by 352
Knäuper, V., Cowell, S., Smith, B., López-Otin, C., O'Shea, M., Morris, H., Zardi, L., & Murphy, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7608 · Cited by 350
Cellular mechanisms of myocardial infarct expansion.
Weisman, H. F., Bush, D. E., Mannisi, J. A., Weisfeldt, M. L., & Healy, B. (1988) · Circulation · doi:10.1161/01.cir.78.1.186 · Cited by 334
Schönbeck, U., Mach, F., Sukhova, G. K., Murphy, C., Bonnefoy, J.-Y., Fabunmi, R. P., & Libby, P. (1997) · Circulation Research · doi:10.1161/01.res.81.3.448 · Cited by 334
Spinale, F. G., Coker, M. L., Krombach, S. R., Mukherjee, R., Hallak, H., Houck, W. V., Clair, M. J., Kribbs, S. B., Johnson, L. L., Peterson, J. T., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.4.364 · Cited by 323
Okada, Y., Naka, K., Kawamura, K., Matsumoto, T., Nakanishi, I., Fujimoto, N., Sato, H., & Seiki, M. (1995) · PubMed · Cited by 303
Bendeck, M. P., Irvin, C., & Reidy, M. A. (1996) · Circulation Research · doi:10.1161/01.res.78.1.38 · Cited by 297
Vaalamo, M., Mattila, L., Johansson, N., Kariniemi, A.-L., Karjalainen-Lindsberg, M.-L., Kähäri, V.-M., & Saarialho-Kere, U. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12276722 · Cited by 287
Disruption of the myocardial extracellular matrix leads to cardiac dysfunction
Kim, H. E., Dalal, S. S., Young, E., Legato, M. J., Weisfeldt, M. L., & D’Armiento, J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8040 · Cited by 281
Zhang, Y., McCluskey, K., Fujii, K., & Wahl, L. M. (1998) · PubMed · Cited by 268
Identification and Characterization of the Fifth Membrane-type Matrix Metalloproteinase MT5-MMP
Pei, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8925 · Cited by 267
Pendás, A. M., Knäuper, V., Puente, X. S., Llano, E., Mattei, M.-G., Apte, S., Murphy, G., & López-Otín, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4281 · Cited by 252
FABUNMI, R. P., BAKER, A. H., MURRAY, E. J., BOOTH, R. F. G., & NEWBY, A. C. (1996) · Biochemical Journal · doi:10.1042/bj3150335 · Cited by 251
Zhang, Y., McCluskey, K., Fujii, K., & Wahl, L. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3071 · Cited by 245
SHALINSKY, D. R., BREKKEN, J., ZOU, H., MCDERMOTT, C. D., FORSYTH, P., EDWARDS, D., MARGOSIAK, S., BENDER, S., TRUITT, G., WOOD, A., et al. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07689.x · Cited by 239
Taraboletti, G., Garofalo, A., Belotti, D., Drudis, T., Borsotti, P., Scanziani, E., Brown, P. D., & Giavazzi, R. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.4.293 · Cited by 235
Regulation of Matrix Metalloproteinase Activitya
MURPHY, G., WILLENBROCK, F., CRABBE, T., O'SHEA, M., WARD, R., ATKINSON, S., O'CONNELL, J., & DOCHERTY, A. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb24722.x · Cited by 222
Preclinical and Clinical Studies of MMP Inhibitors in Cancer
DRUMMOND, A. H., BECKETT, P., BROWN, P. D., BONE, E. A., DAVIDSON, A. H., GALLOWAY, W. A., GEARING, A. J. H., HUXLEY, P., LABER, D., MCCOURT, M., et al. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07688.x · Cited by 219
Activation of human monocytes through CD40 induces matrix metalloproteinases
Malik, N., Greenfield, B. W., Wahl, A. F., & Kiener, P. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3952 · Cited by 206
Okada, Y., Watanabe, S., Nakanishi, I., Kishi, J.-I., Hayakawa, T., Watorek, W., Travis, J., & Nagase, H. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80817-2 · Cited by 199
Role of collagen in acute myocardial infarct expansion.
Whittaker, P., Boughner, D. R., & Kloner, R. A. (1991) · Circulation · doi:10.1161/01.cir.84.5.2123 · Cited by 176
Tyagi, S. C., Matsubara, L., & Weber, K. T. (1993) · Clinical Biochemistry · doi:10.1016/0009-9120(93)90025-2 · Cited by 169
Mauviel, A., Chung, K.-Y., Agarwal, A., Tamai, K., & Uitto, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10917 · Cited by 162
Strauss, B. H., Robinson, R., Batchelor, W. B., Chisholm, R. J., Ravi, G., Natarajan, M. K., Logan, R. A., Mehta, S. R., Levy, D. E., Ezrin, A. M., et al. (1996) · Circulation Research · doi:10.1161/01.res.79.3.541 · Cited by 162
Low Molecular Weight Inhibitors in Corneal Ulcerationa
GALARDY, R. E., CASSABONNE, M. E., GIESE, C., GILBERT, J. H., LAPIERRE, F., LOPEZ, H., SCHAEFER, M. E., STACK, R., SULLIVAN, M., SUMMERS, B., et al. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb24746.x · Cited by 159
Tyagi, S. C., Campbell, S. E., Reddy, H. K., Tjahja, E., & Welker, D. J. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00714328 · Cited by 154
Sato, H., Takino, T., Kinoshita, T., Imai, K., Okada, Y., Stetler Stevenson, W. G., & Seiki, M. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00389-4 · Cited by 150
Disruption of the Plasminogen Gene in Mice Abolishes Wound Healing after Myocardial Infarction
Creemers, E. E., Cleutjens, J. P. M., Smits, J. F. M., Heymans, S. R. B., Moons, L., Collen, D., Daemen, M. J. A. P., & Carmeliet, P. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65060-2 · Cited by 150
Self-citationPreparation and Characterization of Recombinant Tissue Inhibitor of Metalloproteinase 4 (TIMP-4)
Liu, Y. E., Wang, M., Greene, J., Su, J., Ullrich, S. J., Li, H., Sheng, S., Alexander, P., Sang, Q. A., & Shi, Y. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20479 · Cited by 140
Fabunmi, R. P., Sukhova, G. K., Sugiyama, S., & Libby, P. (1998) · Circulation Research · doi:10.1161/01.res.83.3.270 · Cited by 140
Tyagi, S. C., Kumar, S. G., Haas, S. J., Reddy, H. K., Voelker, D. J., Hayden, M. R., Demmy, T. L., Schmaltz, R. A., & Curtis, J. J. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0132 · Cited by 138
Lewis, E. J., Bishop, J., Bottomley, K. M. K., Bradshaw, D. J., Brewster, M., Broadhurst, M. J., Brown, P. A., Budd, J. M., Elliott, L. H., Greenham, A. K., et al. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701150 · Cited by 138
Matrix Metalloproteinase Inhibitor Prevents Acute Lung Injury After Cardiopulmonary Bypass
Carney, D. E., Lutz, C. J., Picone, A., Gatto, L. A., Ramamurthy, N. S., Golub, L. M., Simon, S. R., Searles, B. E., Paskanik, A. M., Snyder, K. P., et al. (1999) · Circulation · doi:10.1161/01.cir.100.4.400 · Cited by 128
Myocardial matrix metalloproteinase activity and abundance with congestive heart failure
Coker, M. L., Thomas, C. V., Clair, M. J., Hendrick, J. W., Krombach, R. S., Galis, Z. S., & Spinale, F. G. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.5.h1516 · Cited by 128
Roten, L., Nemoto, S., Simsic, J. M., Coker, M. L., Rao, V. U., Baicu, S., DeFreyte, G., Soloway, P. D., Zile, M. R., & Spinale, F. G. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1052 · Cited by 127
Metalloproteinase inhibitors and wound healing: A novel enhancer of wound strength
Witte, M. B., Thornton, F. J., Kiyama, T., Efron, D. T., Schulz, G. S., Moldawer, L. L., & Barbul, A. (1998) · Surgery · doi:10.1016/s0039-6060(98)70154-0 · Cited by 123
Identification of MMP-18, a Putative Novel Human Matrix Metalloproteinase
Cossins, J., Dudgeon, T. J., Catlin, G., Gearing, A. J. H., & Clements, J. M. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1688 · Cited by 122
Differential gene expression of extracellular matrix components in dilated cardiomyopathy
Tyagi, S. C., Kumar, S., Voelker, D. J., Reddy, H. K., Janicki, J. S., & Curtis, J. J. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19961101)63:2<185::aid-jcb6>3.0.co;2-u · Cited by 108
Narayanan, A. S., Page, R. C., & Swanson, J. (1989) · Biochemical Journal · doi:10.1042/bj2600463 · Cited by 103
Ito, A., Sato, T., Iga, T., & Mori, Y. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81127-a · Cited by 100
Danielsen, C. C., Wiggers, H., & Andersen, H. R. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0711 · Cited by 99
Feldman, M. D., Erikson, J. M., Mao, Y., Korcarz, C. E., Lang, R. M., & Freeman, G. L. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.4.h1698 · Cited by 93
LIJNEN, H. R., & Collen, D. (1989) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(89)90034-9 · Cited by 75
Murohara, T., Guo, J. P., & Lefer, A. M. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10624-1 · Cited by 54
Cited by
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
KJÆR, M. (2004) · Physiological Reviews · doi:10.1152/physrev.00031.2003 · Cited by 1,586
Oxidative stress and heart failure
Tsutsui, H., Kinugawa, S., & Matsushima, S. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00554.2011 · Cited by 1,231
Metalloproteinase inhibitors: biological actions and therapeutic opportunities
Baker, A. H., Edwards, D. R., & Murphy, G. (2002) · Journal of Cell Science · doi:10.1242/jcs.00063 · Cited by 1,179
Inflammatory Cytokines and Postmyocardial Infarction Remodeling
Nian, M., Lee, P., Khaper, N., & Liu, P. (2004) · Circulation Research · doi:10.1161/01.res.0000130526.20854.fa · Cited by 1,028
Metadata
- Authors
- Creemers, E. E. J. M., Cleutjens, J. P. M., Smits, J. F. M., & Daemen, M. J. A. P.
- Venue
- Circulation Research
- Published
- 2001-08-03
- Volume
- 89
- Issue
- 3
- Pages
- 201-210
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2152090961
- Cited by
- 598
- References
- 74
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.